Campbell & Co Investment Adviser’s Merck MRK Stock Holding History

Campbell & Co Investment Adviser’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,793	Closed	-$402K	–	1304
2025 Q3	$402K	Sell	4,793 -2,136	-31%	-$176K	0.03%	811
2025 Q2	$549K	Sell	6,929 -11,592	-63%	-$921K	0.03%	753
2025 Q1	$1.66M	Buy	18,521 +15,286	+473%	+$1.43M	0.13%	247
2024 Q4	$322K	Sell	3,235 -567	-15%	-$58.5K	0.02%	827
2024 Q3	$432K	Buy	3,802 +1,963	+107%	+$233K	0.03%	769
2024 Q2	$228K	Buy	+1,839	New	+$237K	0.02%	930
2023 Q1	–	Sell	-3,903	Closed	-$433K	–	951
2022 Q4	$433K	Buy	+3,903	New	+$399K	0.1%	379
2022 Q3	–	Sell	-7,625	Closed	-$695K	–	844
2022 Q2	$695K	Sell	7,625 -3,439	-31%	-$305K	0.19%	168
2022 Q1	$908K	Sell	11,064 -36	-0.3%	-$2.84K	0.24%	91
2021 Q4	$851K	Buy	+11,100	New	+$884K	0.29%	85
2019 Q3	–	Sell	-10,648	Closed	-$852K	–	700
2019 Q2	$852K	Buy	+10,648	New	+$815K	0.39%	37

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Campbell & Co Investment Adviser's MRK Position: Q4 2025 in Review

Campbell & Co Investment Adviser sold out of Merck (MRK) in Q4 2025, closing a stake of 4,793 shares — an estimated $402K sold.

Campbell & Co Investment Adviser first reported a position in MRK in Q2 2019 and held it in 11 quarters. The position peaked at $1.66M in Q1 2025. 3,660 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

Campbell & Co Investment Adviser reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
Campbell & Co Investment Adviser sold 4,793 Merck shares in Q4 2025, an estimated $402K.
Campbell & Co Investment Adviser first reported a position in Merck in Q2 2019 and held it in 11 quarters.
Campbell & Co Investment Adviser's Merck position peaked at $1.66M in Q1 2025.
3,660 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2025, filed 12 Feb 2026.